BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is find the highest tolerable dose of BMTP-11 when
given to patients with prostate cancer that has spread. The safety of this drug will also be
studied.